Organon (OGN) Free Cash Flow (2020 - 2026)

Organon (OGN) recorded quarterly Free Cash Flow of $188.0 million in Q1 2026, up 95.83% quarter-over-quarter from $96.0 million in Q4 2025, and up 337.21% on a YoY basis from $43.0 million in Q1 2025.

Organon (OGN) Free Cash Flow (2020 - 2026) Analysis & Trends

Organon's Free Cash Flow history runs 7 years deep, the most recent figure standing at $188.0 million for Q1 2026.

  • In Q1 2026, Free Cash Flow rose 337.21% year-over-year to $188.0 million; the TTM figure through Mar 2026 stood at $683.0 million (down 12.1% YoY), while the FY2025 annual figure was $538.0 million, down 29.58% from the prior year.
  • Free Cash Flow was $188.0 million for Q1 2026 at Organon, up from $96.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $335.0 million in Q4 2024 to a low of -$44.0 million in Q2 2023.
  • Historically, Free Cash Flow has averaged $158.8 million across 5 years, with a median of $181.0 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Free Cash Flow surged 1800.0% in 2022, then slumped 141.51% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $204.0 million in 2022, then soared by 55.88% to $318.0 million in 2023, then gained by 5.35% to $335.0 million in 2024, then plunged by 71.34% to $96.0 million in 2025, then surged by 95.83% to $188.0 million in 2026.
  • The last three Free Cash Flow figures came in at $188.0 million (Q1 2026), $96.0 million (Q4 2025), and $218.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 2.12 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 3.01 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 1.47 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 3.56 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 2.93 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 1.48 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 2.43 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 2.18 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 757.00 Mn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 188.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 188.00 Mn
Mar 31, 2026 188.00 Mn
Dec 31, 2025 96.00 Mn
Dec 31, 2025 96.00 Mn
Sep 30, 2025 218.00 Mn
Sep 30, 2025 218.00 Mn
Jun 30, 2025 181.00 Mn
Jun 30, 2025 181.00 Mn
Mar 31, 2025 43.00 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 335.00 Mn
Dec 31, 2024 335.00 Mn
Sep 30, 2024 99.00 Mn
Sep 30, 2024 99.00 Mn
Jun 30, 2024 300.00 Mn
Jun 30, 2024 300.00 Mn
Mar 31, 2024 30.00 Mn
Mar 31, 2024 30.00 Mn
Dec 31, 2023 318.00 Mn
Dec 31, 2023 318.00 Mn